跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Gemlife-200 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Gemlife-200
Approved
STANDARD
Gemlife-200
ADMAC Lifesciences
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
2d666c9a1156f676
Company
ADMAC Lifesciences
Type
Standard
Approval Details
Approval Id
2d666c9a1156f676
Drug Approval Philippines Name
Gemlife-200
Product Name
Gemlife-200
Registration Number
DRP-14514
Brand Name
Gemlife-200
Generic Name
Gemcitabine (as hydrochloride)
Dosage Form
Lyophilized Powder for Solution for I.V. Infusion
Dosage Strength
200 mg
Manufacturer
ADMAC Lifesciences
Importer
Pharmastar Int'l Trading Corp.
Distributor
Pharmastar Int'l Trading Corp.
Issuance Date
27 September 2023
Expiry Date
27 September 2028
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
2d666c9a1156f676
Type
Standard
Back to Philippines FDA Approvals